DOLLEX
Dollex Agrotech Limited
Dollex Agrotech Limited (DOLLEX) financial statements and selected valuation metrics through 30 June 2026.
Fast Moving Consumer Goods›Fast Moving Consumer Goods›Agricultural Food & other Products›Sugar
Key metrics
Price as of 2026-10-23
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
Company snapshot
23rdBy market cap
Ranked among 27 companies in Sugar.
What we see
- ✓Debt-to-equity of 0.00x — the company is largely funded by its own money, not borrowed funds.
- ✗Operating cash flow is negative even though the company shows a profit — the business may not be generating real cash yet.
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Standalone only
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Sales | 36 Cr | 53 Cr | 27 Cr | 109 Cr | 40 Cr |
| Operating expenses (approx.) | 33 Cr | 51 Cr | 24 Cr | 101 Cr | 37 Cr |
| EBITDA | 4 Cr | 2 Cr | 4 Cr | 8 Cr | 3 Cr |
| OPM % | 9.7% | 4.0% | 13.2% | 7.2% | 8.5% |
| Other income | 0.0069 Cr | 0.23 Cr | 0.0037 Cr | 0.03 Cr | 0.0029 Cr |
| Interest | 0.83 Cr | 0.94 Cr | 1 Cr | 0.85 Cr | 0.86 Cr |
| Depreciation | 0.71 Cr | 0.78 Cr | 0.77 Cr | 0.74 Cr | 0.78 Cr |
| Profit before tax | 2 Cr | 0.62 Cr | 2 Cr | 6 Cr | 2 Cr |
| Tax % | 12.6% | 41.5% | 4.4% | 25.9% | 28.0% |
| Net profit | 2 Cr | 0.36 Cr | 2 Cr | 5 Cr | 1 Cr |
| EPS (₹) | ₹0.62 | ₹0.13 | ₹0.59 | ₹1.25 | ₹0.32 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
| Sales | 237 Cr | 225 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 221 Cr | 208 Cr | Sign in free for the trailing twelve months |
| EBITDA | 16 Cr | 17 Cr | Sign in free for the trailing twelve months |
| OPM % | 6.9% | 7.6% | Sign in free for the trailing twelve months |
| Other income | 0.03 Cr | 0.27 Cr | Sign in free for the trailing twelve months |
| Interest | 3 Cr | 4 Cr | Sign in free for the trailing twelve months |
| Depreciation | 3 Cr | 3 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 10 Cr | 11 Cr | Sign in free for the trailing twelve months |
| Tax % | 21.1% | 20.8% | Sign in free for the trailing twelve months |
| Net profit | 8 Cr | 8 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹3.32 | ₹2.27 | Sign in free for the trailing twelve months |
| Dividend payout % | 0.0% | 0.0% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | 25 Cr | 40 Cr |
| Reserves | 41 Cr | 84 Cr |
| Borrowings | — | — |
| Other liabilities | 217 Cr | 290 Cr |
| Total liabilities | 283 Cr | 414 Cr |
| Fixed assets (net) | 29 Cr | 26 Cr |
| CWIP | — | — |
| Investments | 0 Cr | 0 Cr |
| Inventories | 146 Cr | 97 Cr |
| Trade receivables | 14 Cr | 115 Cr |
| Cash & bank | 0.81 Cr | 2 Cr |
| Other assets | 94 Cr | 175 Cr |
| Total assets | 283 Cr | 414 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Cash from operating activity | -25 Cr | -7 Cr |
| Cash from investing | -47 Cr | -31 Cr |
| Cash from financing | 63 Cr | 39 Cr |
| Net cash flow | -9 Cr | 1 Cr |
| Free cash flow (OCF − Capex) | -76 Cr | -41 Cr |
Ratios
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| ROCE % | 20.9% | 11.6% |
| ROE % | 12.5% | 6.8% |
| Debtor days | 21 | 186 |
| Inventory days | 463 | 771 |
| Days payable | 119 | 886 |
| Cash conversion cycle | 364 | 71 |
| OCF / EBITDA % | -153.7% | -39.6% |
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 2.33 | 1.69 |
| Net debt / EBITDA | -0.05 | -0.11 |